Publications

Riedel, Richard F., Xiaofei Wang, Meg McCormack, Eric Toloza, Gustavo S. Montana, Gilbert Schreiber, and Michael J. Kelley. “Impact of a multidisciplinary thoracic oncology clinic on the timeliness of care..” J Thorac Oncol 1, no. 7 (September 2006): 692–96.

PMID
17409938
Scholars@Duke

Chen, Yongwen, Yun Bai, Jing Yuan, Weihong Chen, Jianya Sun, Hong Wang, Huashan Liang, et al. “Association of polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers..” Cancer Epidemiol Biomarkers Prev 15, no. 9 (September 2006): 1703–7. https://doi.org/10.1158/1055-9965.EPI-06-0291.

PMID
16985033
Full Text

Friedman, H. S. “Spontaneous necrosis influences the accuracy of glioma grading: Comment.” Oncology Report, no. FALL (September 1, 2006): 13–14.

Scholars@Duke

Deeg, H Joachim, Debra Friedman, Vilhelm A. Bohr, Louis Constine, Irene M. Jones, Alice Sigurdson, Gérard Socié, Gary Van Zant, Qingyi Wei, and Paul Martin. “Transplantation and aging..” Biol Blood Marrow Transplant 12, no. 9 (September 2006): 893–98. https://doi.org/10.1016/j.bbmt.2006.04.003.

PMID
16920554
Full Text

Friedman, H. S. “Bevacizumab-irinotecan combination shows activity in recurrent glioma: Comment.” Oncology Report, no. FALL (September 1, 2006).

Scholars@Duke

Zalutsky, M. R., D. A. Reardon, J. A. Quinn, R. E. Coleman, G. Akabani, A. H. Friedman, H. S. Friedman, et al. “Chimeric murine/human IgG(2) anti-tenascin 81C6 monoclonal antibody: phase I trial in patients with malignant glioma of a construct with improved stability.” European Journal of Nuclear Medicine and Molecular Imaging 33 (September 1, 2006): S194–S194.

Scholars@Duke

Sathornsumetee, Sith, Anita B. Hjelmeland, Stephen T. Keir, Roger E. McLendon, David Batt, Timothy Ramsey, Naeem Yusuff, et al. “AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma..” Cancer Res 66, no. 17 (September 1, 2006): 8722–30. https://doi.org/10.1158/0008-5472.CAN-06-0284.

PMID
16951188
Full Text

Friedman, H. S. “Chromosomal translocation confers favorable prognosis in brain tumors: Comment.” Oncology Report, no. FALL (September 1, 2006): 12–13.

Scholars@Duke

Reardon, D. A., M. R. Zalutsky, G. Akabani, R. E. Coleman, A. H. Friedman, R. E. McLendon, H. S. Friedman, J. E. Herndon, J. Kirkpatrick, and D. D. Bigner. “Radioimmunotherapy of patients with malignant brain tumors: patient-specific dosing of I-131-labeled anti-tenacin antibody to achieve 44 Gy boost dose to resection cavity margins.” European Journal of Nuclear Medicine and Molecular Imaging 33 (September 1, 2006): S194–S194.

Scholars@Duke

Pages